Inventor · disambiguated record
Thorsten A. Kirschberg
Also filed as: KIRSCHBERG THORSTEN · KIRSCHBERG THORSTEN A
50 granted patents·39 pending applications·1,383 citations·filing 2000–2025
99Inventor score
Files withGILEAD SCIENCES INC31BIOMEA FUSION INC12TERNS PHARMACEUTICALS INC11CELLGATE INC6GUO HONGYAN5
Top patents by PatentIndex Score
89 records- 0198US8841278B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2013·Granted Sep 23, 2014·20 cites·7 claims
- 0298US8273341B2Antiviral compoundsGUO HONGYAN·Filed 2011·Granted Sep 25, 2012·47 cites·21 claims
- 0398US8088368B2Antiviral compoundsGUO HONGYAN·Filed 2010·Granted Jan 3, 2012·86 cites·23 claims
- 0497US11905299B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 20, 2024·3 cites·3 claims
- 0597US9139604B2Antiviral phosphonate analogsGILEAD SCIENCES INC·Filed 2014·Granted Sep 22, 2015·42 cites·9 claims
- 0697US8871785B2Antiviral phosphonate analogsGILEAD SCIENCES INC·Filed 2013·Granted Oct 28, 2014·49 cites·23 claims
- 0797US8822430B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2013·Granted Sep 2, 2014·17 cites·17 claims
- 0897US8669234B2Antiviral compoundsGUO HONGYAN·Filed 2012·Granted Mar 11, 2014·25 cites·12 claims
- 0997US8575118B2Antiviral compoundsGUO HONGYAN·Filed 2012·Granted Nov 5, 2013·25 cites·4 claims
- 1097US7645747B2Therapeutic phosphonate compoundsGILEAD SCIENCES INC·Filed 2005·Granted Jan 12, 2010·60 cites·29 claims
- 1197US6669951B2Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC·Filed 2001·Granted Dec 30, 2003·148 cites·88 claims
- 1296US11066414B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2019·Granted Jul 20, 2021·10 cites·9 claims
- 1396US8877733B21′-substituted pyrimidine N-nucleoside analogs for antiviral treatmentCHO AESOP·Filed 2012·Granted Nov 4, 2014·55 cites·30 claims
- 1496US8022083B2Antiviral phosphonate analogsGILEAD SCIENCES INC·Filed 2008·Granted Sep 20, 2011·46 cites·29 claims
- 1596US7452901B2Anti-cancer phosphonate analogsGILEAD SCIENCES INC·Filed 2004·Granted Nov 18, 2008·70 cites·13 claims
- 1696US6593292B1Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC·Filed 2000·Granted Jul 15, 2003·163 cites·134 claims
- 1795US9878995B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jan 30, 2018·14 cites·16 claims
- 1895US7229961B2Compositions and methods for enhancing drug delivery across and into ocular tissuesCELLGATE INC·Filed 2002·Granted Jun 12, 2007·55 cites·36 claims
- 1995US6730293B1Compositions and methods for treating inflammatory diseases of the skinCELLGATE INC·Filed 2000·Granted May 4, 2004·83 cites·23 claims
- 2094US9511056B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Dec 6, 2016·7 cites·9 claims
- 2194US6759387B2Compositions and methods for enhancing drug delivery across and into epithelial tissuesCELLGATE INC·Filed 2002·Granted Jul 6, 2004·67 cites·31 claims
- 2293US10328053B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 25, 2019·4 cites·7 claims
- 2392US12240835B2Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activityTERNS PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·1 cites·4 claims
- 2492US10316017B2COT modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Jun 11, 2019·12 cites·30 claims
- 2592US9815818B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2016·Granted Nov 14, 2017·13 cites·32 claims
- 2692US8623833B2Compositions and methods for enhancing drug delivery across and into epithelial tissuesROTHBARD JONATHAN B·Filed 2010·Granted Jan 7, 2014·18 cites·25 claims
- 2791US11203587B2Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2019·Granted Dec 21, 2021·6 cites·21 claims
- 2891US10800767B2Thyroid hormone receptor beta agonist compoundsTERNS INC·Filed 2019·Granted Oct 13, 2020·11 cites·21 claims
- 2991US10577352B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2018·Granted Mar 3, 2020·10 cites·20 claims
- 3091US10059695B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2017·Granted Aug 28, 2018·12 cites·28 claims
- 3190US10889571B2Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemiasTERNS INC·Filed 2019·Granted Jan 12, 2021·4 cites·34 claims
- 3290US8278264B2Compositions and methods for enhancing drug delivery across and into ocular tissuesROTHBARD JONATHAN B·Filed 2007·Granted Oct 2, 2012·7 cites·28 claims
- 3390US7417055B2Kinase inhibitory phosphonate analogsGILEAD SCIENCES INC·Filed 2004·Granted Aug 26, 2008·37 cites·14 claims
- 3490US7407965B2Phosphonate analogs for treating metabolic diseasesGILEAD SCIENCES INC·Filed 2004·Granted Aug 5, 2008·27 cites·12 claims
- 3589US7432261B2Anti-inflammatory phosphonate compoundsGILEAD SCIENCES INC·Filed 2004·Granted Oct 7, 2008·24 cites·20 claims
- 3689US7429565B2Antiviral phosphonate analogsGILEAD SCIENCES INC·Filed 2004·Granted Sep 30, 2008·25 cites·20 claims
- 3788US9981955B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted May 29, 2018·2 cites·20 claims
- 3888US8729010B2Compositions and methods for enhancing drug delivery across and into ocular tissuesROTHBARD JONATHAN B·Filed 2012·Granted May 20, 2014·5 cites·20 claims
- 3988US7470724B2Phosphonate compounds having immuno-modulatory activityGILEAD SCIENCES INC·Filed 2004·Granted Dec 30, 2008·23 cites·20 claims
- 4088US7427636B2Inosine monophosphate dehydrogenase inhibitory phosphonate compoundsGILEAD SCIENCES INC·Filed 2004·Granted Sep 23, 2008·21 cites·18 claims
- 4187US10874640B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2019·Granted Dec 29, 2020·2 cites·5 claims
- 4286US8106064B2Pyrimidine-2,4-dione HIV reverse transcriptase inhibitorsGUO HONGYAN·Filed 2007·Granted Jan 31, 2012·6 cites·36 claims
- 4385US2025346609A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4485US2024254137A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 4582US7427624B2Purine nucleoside phosphorylase inhibitory phosphonate compoundsGILEAD SCIENCES INC·Filed 2004·Granted Sep 23, 2008·12 cites·18 claims
- 4681US7432273B2Phosphonate analogs of antimetabolitesGILEAD SCIENCES INC·Filed 2004·Granted Oct 7, 2008·9 cites·8 claims
- 4780US12161625B2Substituted pyrrolizine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Dec 10, 2024·0 cites·23 claims
- 4880US2024316025A1Combination treatment of liver disordersTERNS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4978US12454524B2(r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemiasTERNS PHARMACEUTICALS INC·Filed 2025·Granted Oct 28, 2025·0 cites·30 claims
- 5075US2024000765A1Combination treatment of liver disordersTERNS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →